Arterial intracranial thrombosis as the first manifestation of vaccine-induced immune thrombotic thrombocytopenia (VITT): a case report
- 13 January 2022
- journal article
- research article
- Published by Springer Science and Business Media LLC in Neurological Sciences
- Vol. 43 (3), 2085-2089
- https://doi.org/10.1007/s10072-021-05800-3
Abstract
Objective We describe a severe case of vaccine-induced immune thrombotic thrombocytopenia (VITT) after the first dose of the ChAdOx1 nCoV-19 vaccine leading to massive ischemic stroke. Methods A 42-year-old woman developed acute left hemiparesis (NIHSS 12) 9 days after the first vaccine dose. Results The blood tests revealed low platelets (70 103/μL) and severe increment of D-dimer (70,745 ng/mL FEU). Brain non-contrast computed tomography and multiphasic CT angiography demonstrated a right middle cerebral artery occlusion. The patient was treated with primary thrombectomy, steroids, immunoglobulin, and fondaparinux. Despite the treatment, the neurological status deteriorated and underwent decompressive hemicraniectomy. She was transferred to the rehab’s unit 52 days after the onset. Discussion Healthcare providers should be aware of the possibility of ischemic stroke as a manifestation of VITT. Awareness on this very rare and possibly fatal complication should be reinforced on both the vaccine recipients and general practitioners.Keywords
This publication has 14 references indexed in Scilit:
- Adenovirus-Vectored COVID-19 Vaccine–Induced Immune Thrombosis of Carotid ArteryNeurology, 2021
- COVID‐19 Vaccine‐Associated Cerebral Venous Thrombosis in GermanyAnnals of Neurology, 2021
- Post‐SARS‐CoV‐2‐vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines AgencyEuropean Journal of Neurology, 2021
- Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopeniaNature Communications, 2021
- Thrombosis and thrombocytopaenia after ChAdOx1 nCoV-19 vaccination: a single UK centre experienceBMJ Case Reports, 2021
- Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): a position statement from the Italian Society for the Study of Haemostasis and Thrombosis (SISET)2021
- A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2Blood Advances, 2021
- SARS-CoV-2 Vaccine–Induced Immune Thrombotic ThrombocytopeniaThe New England Journal of Medicine, 2021
- Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopeniaJournal of Neurology, Neurosurgery & Psychiatry, 2021
- Coronavirus vaccine development: from SARS and MERS to COVID-19Journal of Biomedical Science, 2020